• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “assistly” Archives

          in
          Entry Author Date Location
          Get Satisfaction Makes Customer Support Less Robotic-And More Strategic Wade Roush 11/29/11 San Francisco
          Lithium Helps Companies Rev Up Customer Support by Deputizing ‘Superfans’ Wade Roush 09/29/11 San Francisco
          Salesforce Acquires Assistly for $50,000,000 VentureDeal 09/22/11 San Francisco
          Salesforce.com Snaps Up Assistly in Race to Dominate Customer Service Technology Wade Roush 09/21/11 San Francisco
          Instructables, Assistly, Airbnb: The 1-Minute Version of Last Week’s Bay Area BizTech News Wade Roush 08/02/11 San Francisco
          Assistly’s Pricing Gamble: A Case Study in Freemium Wade Roush 07/26/11 San Francisco
          When Complaining Customers Hit Twitter and Facebook, Assistly is There Wade Roush 07/12/11 San Francisco
          True Ventures Looks for Magic in the Crowd of Portfolio CEOs, Not Its Partners’ Brains Wade Roush 06/30/11 San Francisco
          Google Makes Smartphones Smarter, Salesforce.com Continues Acquisition Binge, & More Bay Area BizTech News Wade Roush 01/10/11 San Francisco
          $3M Assist for Assistly Wade Roush 01/04/11 San Francisco
          Assistly Receives $2,200,000 Series A Funding VentureDeal 04/14/10 San Francisco
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Robert Langer reveals secrets to early-stage biotech success

            From Our Partners · Special Report

            Robert Langer reveals secrets to early-stage biotech success

            Advice for funding and future transformational opportunities

          • Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes

            Sponsored · Webinar

            Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes

            Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates

            Eurofins DiscoverX
          • The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Sponsored · Whitepaper

            The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars

            IBM Watson

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.